No Result
View All Result
Success American Investors
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Success American Investors
No Result
View All Result
Home Editor's Pick

How Pharmacists Can Increase Access to Routine Health Care

by
March 21, 2024
in Editor's Pick
0
How Pharmacists Can Increase Access to Routine Health Care
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Marc Joffe and Jeffrey A. Singer

How often do people have to leave work early for a medical appointment and wait for an hour for the doctor to perform a simple test and prescribe a routine medication that they knew in advance would happen? Like a routine urinary tract infection? Or a strep throat? Imagine if they could stop off at their local pharmacy on the way home from work, ask the pharmacist to perform the simple test, and prescribe the medication for the routine condition. There are several jurisdictions—including three states—where this convenience and accessibility is a reality.

Our new policy briefing paper, Let Pharmacists Prescribe, explores a reform that would improve the quality of US healthcare while partially addressing the shortage of primary care physicians. We propose that states allow pharmacists to leverage their education and experience to safely prescribe a wider range of medications to their customers.

The traditional arrangement under which physicians prescribe and pharmacists dispense has already been breached throughout the United States. During the COVID-19 pandemic, the federal government authorized pharmacists to dispense Paxlovid without a prescription on the grounds that patients needed to start taking the anti‐​viral medication soon after being diagnosed, so there was no time to wait for a doctor’s visit. States have also reached a similar conclusion about Naloxone (marketed as Narcan), which reverses the effects of opioid overdose if administered quickly. Several states authorize pharmacists to prescribe birth control pills and HIV prevention.

But shouldn’t a policy that works for COVID-19, drug overdoses, birth control, and HIV prophylaxis be applicable to other conditions?

In our paper, we consider the cases of Alberta, Ontario, and Queensland (Australia), all of which have extended pharmacist prescribing to more than a dozen common conditions. In the first six months of 2023 alone, Ontario pharmacists wrote over 250,000 prescriptions.

Among US states, Idaho has taken the lead in broadening pharmacist prescribing, specifying four general categories under which they may prescribe. Subsequently, Montana and Colorado enacted similar legislation.

When considering prescribing a medication, physicians often consult with pharmacists about interactions with drugs the patient is already taking. Pharmacists are well qualified to address such inquiries because they interact with a large number of patients and most receive as much classroom training as physicians.

States should eliminate unnecessary requirements for people to see doctors to make simple diagnoses and prescribe medicines. Patients should be allowed to go directly to the pharmacy, freeing up physicians for higher priorities and removing a hurdle for patients seeking relief.

Previous Post

Diversifying Your Portfolio: Different Types of Mutual Funds and How They Are Priced

Next Post

Looking Back at the Crossroads: Liberty or Socialism

Next Post

Looking Back at the Crossroads: Liberty or Socialism

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

February 14, 2024
Idaho Bucks Managed Care Trend

Idaho Bucks Managed Care Trend

December 5, 2023

Last Day to Give in 2023!

December 31, 2023

The Producer Price Index

September 9, 2023

“SocialBox.Biz Launches MacBook and Laptop Reuse Program to Amplify Corporate Social Responsibility Efforts”

0

0

0

0

“SocialBox.Biz Launches MacBook and Laptop Reuse Program to Amplify Corporate Social Responsibility Efforts”

May 23, 2025
UK energy bills to fall by £129 from July as Ofgem cuts price cap by 7%

UK energy bills to fall by £129 from July as Ofgem cuts price cap by 7%

May 23, 2025
AI could consume nearly half of global datacentre power by year-end, new analysis warns

AI could consume nearly half of global datacentre power by year-end, new analysis warns

May 23, 2025
UK private sector activity contracts for second month, raising fears of economic slowdown

UK private sector activity contracts for second month, raising fears of economic slowdown

May 23, 2025

Recent News

“SocialBox.Biz Launches MacBook and Laptop Reuse Program to Amplify Corporate Social Responsibility Efforts”

May 23, 2025
UK energy bills to fall by £129 from July as Ofgem cuts price cap by 7%

UK energy bills to fall by £129 from July as Ofgem cuts price cap by 7%

May 23, 2025
AI could consume nearly half of global datacentre power by year-end, new analysis warns

AI could consume nearly half of global datacentre power by year-end, new analysis warns

May 23, 2025
UK private sector activity contracts for second month, raising fears of economic slowdown

UK private sector activity contracts for second month, raising fears of economic slowdown

May 23, 2025

Disclaimer: SuccessAmericanInvestors.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.